Generali Investments Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Buy
10,220
+1,521
+17% +$1.55M 2.66% 9
2026
Q1
$8M Sell
8,699
-2,724
-24% -$2.76M 1.86% 12
2025
Q4
$12.3M Sell
11,423
-1,144
-9% -$1.09M 2.45% 11
2025
Q3
$9.59M Buy
12,567
+3,281
+35% +$2.44M 2% 12
2025
Q2
$7.23M Buy
9,286
+6
+0.1% +$4.66K 1.64% 12
2025
Q1
$7.66M Sell
9,280
-1,624
-15% -$1.35M 2.18% 8
2024
Q4
$8.42M Buy
+10,904
New +$9.03M 2.18% 9

Other funds holding LLY

Generali Investments Management's LLY Position: Q2 2026 in Review

Generali Investments Management increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $1.55M and bringing the position to 10,220 shares worth $12.3M. The position accounts for 2.66% of the portfolio, ranked #9.

Generali Investments Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.3M in Q4 2025. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Generali Investments Management held 10,220 shares of Eli Lilly worth $12.3M as of Q2 2026.
  • Generali Investments Management bought 1,521 Eli Lilly shares in Q2 2026, an estimated $1.55M.
  • Eli Lilly made up 2.66% of Generali Investments Management's portfolio in Q2 2026, its #9 holding.
  • Generali Investments Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments Management's Eli Lilly position peaked at $12.3M in Q4 2025.
  • 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.